Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy

Journal of the Neurological Sciences

Volumn 151, Issue 1, 1997, Pages 97-101

  Shirabe, Susumu ^a   Nakamura, Tatsufumi ^a   Tsujino, Akira ^a   Nishiura, Yoshihiro ^a   Furuya, Takafumi ^a   Goto, Hirofumi ^a   Suenaga, Akihito ^a   Nakane, Shunya ^a   Yoshimura, Toshiro ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

HTLV I associated myelopathy; Pentoxifylline; Spontaneous lymphocyte proliferation; TNF

Indexed keywords

PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD DISEASE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; PENTOXIFYLLINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS; VIRAL LOAD;

EID: 18744418672     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00074-9     Document Type: Article

References (12)

1. Arvin, B., Neville, L.F., Barone, F.C., Feuerstein, G.Z., 1995 Brain injury and inflammation. A putative role of TNF-α. Ann. New York Acad. Sci. 765: 62-71.
2. Fazely, F., Dezube, B.J., Allen-Ryan, J., Pardee, A.B., Ruprecht, R.M., 1991 Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 77: 1653-1656.
3. Ichinose, K., Nakamura, T., Nishiura, Y., Nagasato, K., Ohishi, K., Watanabe, H., Fujita, A., Kurouji, K., Tsujihata, M., Nagataki, S., 1994 Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy. J. Neurol. Sci. 122: 204-209.
4. Matsuo, H., Nakamura, T., Tsujihata, M., Kinoshita, I., Satoh, A., Tomita, I., Shirabe, S., Shibayama, K., Nagataki, S., 1988 Plasmapheresis in treatment of human T-lymphotropic virus type-I-associated myelopathy. Lancet 2: 1109-1113.
5. Nagasato, K., Nakamura, T., Ichinose, K., Nishiura, Y., Ohishi, K., Shibayama, K., Watanabe, H., Tsujihata, M., Nagataki, S., 1993 Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: a preliminary study. J. Neurol. Sci. 115: 161-168.
6. Nakamura, T., Shirabe, S., Ichinose, K., Nishiura, Y., Watanabe, H., Suenaga, A., Yoshimura, T., Tsujihata, M., Nagataki, S., 1995 Pentoxifylline treatment in HTLV-I-associated myelopathy. Intern. Med. 34: 460.
7. Osame, M., Matsumoto, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Tara, T., Igata, A., 1987 Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukaemia-like cells. Ann. Neurol. 21: 117-122.
8. Samlaska, C.P., Winfield, E.A., 1994 Pentoxifylline. J. Am. Acad. Dermatol. 30: 603-621.
9. Shibayama, K., Nakamura, T., Nagasato, K., Shirabe, S., Tsujihata, M., Nagataki, S., 1991 Interferon-alpha treatment in HTLV-I-associated myelopathy studies of clinical and immunological aspects. J. Neurol. Sci. 106: 186-192.
10. Tsujino, A., Nakamura, T., Nishiura, Y., Shirabe, S., Furuya, T., Goto, H., Kawakami, A., Eguchi, K., Nagataki, S., 1997. Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy. J. Neuroimmunol. 73: 191-196.
11. Ward, A., Clissold, S.P., 1987 Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50-97.
12. Watanabe, H., Nakamura, T., Nagasato, K., Shirabe, S., Ohishi, K., Ichinose, K., Nishiura, Y., Chiyoda, S., Tsujihata, M., Nagataki, S., 1995 Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. Arch. Neurol. 52: 276-280.